Bausch Health Cos Income After Taxes 2010-2024 | BHC
Bausch Health Cos income after taxes from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Bausch Health Cos Annual Income After Taxes (Millions of US $) |
2023 |
$-611 |
2022 |
$-212 |
2021 |
$-937 |
2020 |
$-559 |
2019 |
$-1,783 |
2018 |
$-4,144 |
2017 |
$2,404 |
2016 |
$-2,408 |
2015 |
$-288 |
2014 |
$880 |
2013 |
$-864 |
2012 |
$-116 |
2011 |
$160 |
2010 |
$-208 |
2009 |
$176 |
Bausch Health Cos Quarterly Income After Taxes (Millions of US $) |
2024-09-30 |
$-92 |
2024-06-30 |
$-1 |
2024-03-31 |
$-77 |
2023-12-31 |
$-47 |
2023-09-30 |
$-382 |
2023-06-30 |
$27 |
2023-03-31 |
$-209 |
2022-12-31 |
$-410 |
2022-09-30 |
$403 |
2022-06-30 |
$-139 |
2022-03-31 |
$-66 |
2021-12-31 |
$72 |
2021-09-30 |
$191 |
2021-06-30 |
$-593 |
2021-03-31 |
$-607 |
2020-12-31 |
$-152 |
2020-09-30 |
$70 |
2020-06-30 |
$-325 |
2020-03-31 |
$-152 |
2019-12-31 |
$-1,517 |
2019-09-30 |
$-48 |
2019-06-30 |
$-170 |
2019-03-31 |
$-48 |
2018-12-31 |
$-342 |
2018-09-30 |
$-351 |
2018-06-30 |
$-872 |
2018-03-31 |
$-2,579 |
2017-12-31 |
$512 |
2017-09-30 |
$1,300 |
2017-06-30 |
$-37 |
2017-03-31 |
$629 |
2016-12-31 |
$-512 |
2016-09-30 |
$-1,219 |
2016-06-30 |
$-304 |
2016-03-31 |
$-373 |
2015-12-31 |
$-387 |
2015-09-30 |
$52 |
2015-06-30 |
$-52 |
2015-03-31 |
$99 |
2014-12-31 |
$502 |
2014-09-30 |
$276 |
2014-06-30 |
$122 |
2014-03-31 |
$-20 |
2013-12-31 |
$125 |
2013-09-30 |
$-972 |
2013-06-30 |
$11 |
2013-03-31 |
$-28 |
2012-12-31 |
$-89 |
2012-09-30 |
$8 |
2012-06-30 |
$-22 |
2012-03-31 |
$-13 |
2011-12-31 |
$56 |
2011-09-30 |
$41 |
2011-06-30 |
$56 |
2011-03-31 |
$6 |
2010-12-31 |
$-31 |
2010-09-30 |
$-208 |
2010-06-30 |
$34 |
2010-03-31 |
$-3 |
2009-12-31 |
$73 |
2009-09-30 |
$40 |
2009-06-30 |
$24 |
2009-03-31 |
$39 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$3.358B |
$8.757B |
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|